Market Overview

Lupin Says Received FDA Approval for Generic Lexapro

Related FRX
Icahn: I Believe It'll All Work Out With Freeport-McMoRan
Activis Shares Languish Post-Forest Deal

Pharma major, Lupin Ltd., announced today that its subsidiary Lupin Pharmaceuticals Inc. (collectively, Lupin) has received final approval for its Escitalopram Tablets (Escitalopram oxalate) 5 mg, 10 mg, and 20 mg, from the United States Food and Drugs Administration (FDA) to market a generic version of Forest Laboratories, Inc.'s (Forest) Lexapro Tablets, 5 mg, 10 mg, and 20 mg.

Posted-In: News FDA


Related Articles (FRX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters